AXS Investments’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$48.1K Sell
525
-33
-6% -$2.89K 0.01% 165
2026
Q1
$47.6K Sell
558
-267
-32% -$23.8K 0.02% 160
2025
Q4
$65.2K Sell
825
-150
-15% -$11.8K 0.02% 162
2025
Q3
$77.9K Buy
+975
New +$83.2K 0.02% 159
2024
Q1
– Sell
-1,349
Closed -$108K – 322
2023
Q4
$108K Sell
1,349
-102
-7% -$7.67K 0.03% 326
2023
Q3
$103K Sell
1,451
-547
-27% -$40.9K 0.03% 300
2023
Q2
$154K Sell
1,998
-404
-17% -$31.3K 0.04% 277
2023
Q1
$181K Sell
2,402
-163
-6% -$12.1K 0.06% 217
2022
Q4
$202K Sell
2,565
-330
-11% -$24.7K 0.07% 195
2022
Q3
$203K Sell
2,895
-455
-14% -$35.7K 0.08% 199
2022
Q2
$268K Sell
3,350
-580
-15% -$45.4K 0.1% 192
2022
Q1
$298K Sell
3,930
-5,387
-58% -$427K 0.12% 111
2021
Q4
$795K Buy
+9,317
New +$728K 0.19% 89
2021
Q3
– Sell
-6,335
Closed -$515K – 124
2021
Q2
$515K Buy
6,335
+1,142
+22% +$93.4K 0.16% 119
2021
Q1
$409K Buy
+5,193
New +$407K 0.15% 116

Other funds holding CL

AXS Investments's CL Position: Q2 2026 in Review

AXS Investments reduced its Colgate-Palmolive (CL) stake by 5.9% in Q2 2026, selling an estimated $2.89K and leaving 525 shares worth $48.1K. The position accounts for 0.01% of the portfolio, ranked #165.

AXS Investments first reported a position in CL in Q1 2021 and has held it in 15 quarters since. The position peaked at $795K in Q4 2021. 2,028 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • AXS Investments held 525 shares of Colgate-Palmolive worth $48.1K as of Q2 2026.
  • AXS Investments sold 33 Colgate-Palmolive shares in Q2 2026, an estimated $2.89K.
  • Colgate-Palmolive made up 0.01% of AXS Investments's portfolio in Q2 2026, its #165 holding.
  • AXS Investments first reported a position in Colgate-Palmolive in Q1 2021 and has held it in 15 quarters since.
  • AXS Investments's Colgate-Palmolive position peaked at $795K in Q4 2021.
  • 2,028 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on AXS Investments's 13F filing for Q2 2026, filed 10 Aug 2026.